2Funauchi M,Sugiyama M,SukYoo B. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus[J].LUPUS,2001,(04):284-288.
3D'Agati VD,Appel GB,Estes D. Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis[J].Kidney International,1986,(04):573-581.
4Dolff S,Abdulahad WH,van Dijk MC. Urinary T cells in active lupus nephritis show an effector memory phenotype[J].ANNALS OF THE RHEUMATIC DISEASES,2010,(11):2034-2041.
5Dolff S,Abdulahad WH,Arends S. Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis[J].Arthritis Research & Therapy,2013,(01):R36.
6Enghard P,Rieder C,Kopetschke K. Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response[J].ANNALS OF THE RHEUMATIC DISEASES,2013.
7Wen J,Xia Y,Stock A. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway[J].Journal of Autoimmunity,2013.44-54.
8Liu ZC,Zhou QL. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis[J].Inflammation Research,2012,(04):277-284.
9Schwartz N,Su L,Burkly LC. Urinary TWEAK and the activity of lupus nephritis[J].Journal of Autoimmunity,2006,(04):242-250.
10Zhao Z,Burkly LC,Campbell S. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus[J].Journal of Immunology,2007,(11):7949-7958.
2Mok CC.Prognostic factors in lupus nephritis[J].Lupus,2005,14(1):39-44.
3Tarif N,Alwakeel JS,Mitwalli AH,et al.Serum cystatin C as a marker of renal function in patients with acute renal failure[J].Saudi J Kidney Dis Transpl,2008,19(6):918-923.
4Devarajan P,Williams LM.Proteomics for biomarker discovery in acute kidney injury[J].Semin Nephrol,2007,27(6):637-651.
5Stevens LA,Coresh J,Schmid CH,et al.Estimating GFR using serum cystatin C alone and in combination with serum creatinine:a pooled analysis of 3 418 individuals with CKD[J].Am J Kidney Dis,2008,51(3):395-406.
6Wakeel JS,Hammad D,Memon NA,et al.Serum cystatin C:a surrogate marker for the characteristics of peritoneal membrane in dialysis patients[J].Saudi J Kidney Dis Transpl,2009,20(2):227-231.
7Vaidya VS,Waikar SS,Ferguson MA,et al.Biomarkers for sensitive and specific detection of acute kidney injury in humans[J].Clin Transl Sci,2008,1(3):200-208.
8Conti M,Moutereau S,Zater M,et al.Urinary cystatin C as a specific marker of tubular dysfunction[J].Clin Chem Lab Med,2006,44(3):288-291.
9Mereadal L, Montcel ST, Nochy D, et al. Factors affecting outcome and prognosis in membranous lupus nephropathy[J].Nephrol Dial Transplant, 2002,17(10) : 1771- 1778.
10Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997,40(9) : 1725.
